Insightful Expert Interviews | Pharma Industry Strategies

Porton Pharma Solutions and Codexis Launch Global Partnership

CODEXIS + PORTON

PARTNERSHIP

Codexis, Inc. and Porton Pharma Solutions, Ltd. announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business. The partnership will accelerate the creation and commercialization of new, low-cost, sustainable manufacturing processes, exploiting the benefits of biocatalysts to a growing number of the world’s small molecule pharmaceuticals.

European Lead Factory

Ton Rijnders

Head of European Screening Centre

Ton Rijnders is the Head of Screening at the European Lead Factory. He holds a Ph.D. in molecular biology and has an extensive experience with drug discovery in pharma, with increasing managerial and scientific responsibilities. Since November 2017, Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature.

Datwyler Pharma Packaging

Dr. Renaud Janssen

Senior Manager Global Scientific Affairs

Renaud Janssen, Ph.D. is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging. He frequently presents on international conferences on subjects related to elastomeric and aluminium/plastic closures for pharmaceutical applications. Renaud also serves on several standardisation and pharmacopoeia committees, as well as on industry task forces.

University of Lincoln, UK

Dr. Ishwar Singh

Senior Lecturer, School of Pharmacy

Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy, University of Lincoln. Prior to Lincoln, he had held many prestigious fellowships such as the Alexander von Humboldt fellowship, Germany; and Senior Research Fellowship, DANIDA, Denmark and CSIR, India. He is an organic chemist. He has developed bioconjugations for DNA, RNA and polymer modifications in water. He is currently leading research in Biologics delivery, Peptides, Sequence selective DNA cross linking, Nanoparticles modifications for drug delivery and diagnostic applications and broad spectrum antibiotics.

Powder Systems Limited

Pierre Landais, MEng

Tendering Manager Asia-Pacific

Powder Systems Limited (PSL) has been exporting its technology to the Asia-Pacific market since 1990 and a growing number of turn-key installations are to be commissioned in this region in the future. To support the demand, PSL has committed to further investment in Asia-Pacific (APAC) by opening an engineering and sales office in Singapore. This addition to PSL APAC will reinforce the fast growing activities coming from South East Asia, South Korea, Japan, Australia, India and China.

ExpreS2ion Biotechnologies

Sancha Salgueiro, Ph.D., MBA

Vice President - Business Development

ExpreS2ion Biotechnologies’ protein expression system ExpreS2 is an important protein expression tool in the scientist’s tool box for protein expression. The ExpreS2 platform has demonstrated in many instances its usefulness in R&D, with several ExpreS2-made proteins having now been crystallized.

Takeda Pharmaceutical Company Limited

Andrew Plump, M.D., Ph.D

Chief Medical & Scientific Officer

Scientific progress depends upon collaboration. iPS cell technology is at the forefront of pharmaceutical innovation, and Takeda strives to bring innovative treatments to patients. Both Takeda and CiRA have the common goal of providing patients and healthcare professionals with innovative new treatments.

Thomson Reuters

Wendy Hamilton

Senior Vice President

We believe publications such as Pharmafocus Asia are essential in providing professionals with insights into the dynamic and evolving trends of the Pharma industry.

Interpharm Consultancy

Peter Wittner

Founder

Interpharm Consultancy has been providing advice about the UK generic market and consultancy services to generic manufacturers and distributors.

Bioquell Asia Pacific,

Green Shoots of Growth

Managing Director

Bioquell Asia Pacific, based in Singapore, in April 2009 to be the regional office for our activities in Asia and Australasia. I am responsible for the development of our business throughout the region and for the success and profitability of our activities. We provide equipment and services for environmental bio-decontamination across the pharmaceutical therapeutic development